American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays.
about
Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal MedicinePrediction of Cancer Drug Resistance and Implications for Personalized MedicinePrecision medicine for cancer with next-generation functional diagnosticsRecent applications of chemosensitivity tests for colorectal cancer treatmentCancer biomarkersTumour biomarkers: homeostasis as a novel prognostic indicatorSpecial Technologies for Ex Vivo Analysis of CancerApplication of a drug-induced apoptosis assay to identify treatment strategies in recurrent or metastatic breast cancerIn vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index.In vitro chemoresponse to cisplatin and outcomes in cervical cancer.Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.Overview of a chemoresponse assay in ovarian cancerEvaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective studyCorrelation of the microculture-kinetic drug-induced apoptosis assay with patient outcomes in initial treatment of adult acute myelocytic leukemia.Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.Metabolomics of the tumor microenvironment in pediatric acute lymphoblastic leukemia.Three-dimensional organotypic culture: experimental models of mammalian biology and disease.State of oncology practice.Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis.Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy--the SpheroNEO study.Use of ChemoFx® for Identification of Effective Treatments in Epithelial Ovarian CancerMicroC(3): an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells.Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastasesTopoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response.Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancerMarketing of personalized cancer care on the web: an analysis of Internet websitesExploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial)Theranostic barcoded nanoparticles for personalized cancer medicinePeek before you treat? Is it a fantasy or reality?Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts.Drug sensitivity testing platforms for gastric cancer diagnostics.Distinctive behaviour of live biopsy-derived carcinoma cells unveiled using coherence-controlled holographic microscopy.Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer.Multiplexed Dosing Assays by Digitally Definable Hydrogel Volumes.Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvementTrace Elements and Chemotherapy Sensitivity.Rapid assessment of drug response in cancer cells using microwell array and molecular imaging.Molecular and Functional Diagnostic Tools in Precision Oncology for Urological Malignancies.
P2860
Q26741336-C15CC025-57D3-4D10-8DB1-C6F3E3DB5EC3Q26770581-E0E6D124-10F4-4B20-859F-E109400980EDQ26780232-D0C41EEC-43F4-4AAA-A2D7-A255CF4D23F6Q26851075-7648B2C0-E1F6-4478-8047-2EA705224282Q26864429-983506C1-8E2C-4A41-A771-47D0A3E19D9AQ28069898-0B0DF5F7-FCDF-4816-9665-F5DCCECA8347Q28087644-1FB96EB9-D2FB-49B7-A66B-8444B34EED24Q28547641-B0BD14CA-7853-4075-88AC-A8EF12AEB1CFQ30665874-FB3697E2-18F8-4C07-9CDF-1F1DE1E8957AQ33597675-B5DB51FF-72D3-430E-89EB-E7E46C029C35Q33739680-EEAF0FCF-0605-49E9-8B67-96C6477C7941Q34071625-EBA855AD-7C1C-4CB8-BB44-E74E226BCE10Q34113564-802378EA-E520-4469-B0D8-A8AFA7DCFB35Q34296130-DCD58335-80D4-4C70-BFC4-AE26D2B7D63DQ34362184-5BB6F8C4-2CE0-418A-80E8-4D5C50F403D6Q35070594-C152FFF2-64F0-4AEC-AFE5-42F99DDE6C9DQ35155660-B7C520E1-9166-4331-9872-5B7DC13865EBQ35205649-89F7E18D-12CA-49FD-83A0-290D9E34B5E2Q35337927-C47A85BA-BC18-4170-831A-670724744AE6Q35653726-1D798CB2-0ECD-4F9F-80BE-01B51EE4E3B5Q35689902-4AD4DB7B-3DB7-4E7D-8D1C-29B25B34E60BQ35715271-2BFA7B53-CB8A-48C6-AEF8-6262006C0467Q35766816-1C18D3D5-0D05-426B-AC2D-03E023DA8E3CQ36238283-856F7242-D73F-4062-8EED-32713EA32C7AQ36246729-26F8C9B6-22C5-45A8-A649-7A2B7B7630BAQ36341003-96B697BF-45A8-46F6-8F82-3F0F877363A8Q36485454-772E0C11-1EAB-47F3-AA2B-67D8876C086BQ36770241-CE2C31E6-0E98-4D81-8650-194997DD06A1Q36778096-03878D9D-CC14-4B12-B7DC-69237D89A591Q37414318-347DAE45-02C4-428A-810E-FEF25D5C9A32Q38364708-EBCD1E86-CCEA-46BF-8F9D-3825D197FBF1Q38611166-B4FACBEC-D77C-4028-8DF2-D0502A472B54Q38633116-F10B8A75-0055-4F75-937C-63B53EE1FCF5Q38636694-A1684150-8947-4533-ABF1-B09575DDAA38Q38692850-7B9D0460-09BD-4A20-9CAB-940D610FEE43Q38815777-AEDCA97E-8A11-4FCE-AF49-30A91DCEFB1CQ38842969-50E8EAF8-041A-4565-8A21-4E9C7367C2E5Q38897329-F8B76C6B-ADC4-4523-A656-6DE0FCBB4B42Q39001610-1D3E5331-6E92-4032-8235-22A0DB497290Q39105730-5E3F2B1A-0B76-4EB1-9C63-3F0C63D2DD5F
P2860
American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
American Society of Clinical O ...... itivity and resistance assays.
@ast
American Society of Clinical O ...... itivity and resistance assays.
@en
type
label
American Society of Clinical O ...... itivity and resistance assays.
@ast
American Society of Clinical O ...... itivity and resistance assays.
@en
prefLabel
American Society of Clinical O ...... itivity and resistance assays.
@ast
American Society of Clinical O ...... itivity and resistance assays.
@en
P2093
P356
P1476
American Society of Clinical O ...... itivity and resistance assays.
@en
P2093
David Samson
Deborah Schrag
Debra Zelman
Harold J Burstein
Jaffer A Ajani
Lawrence Holt
Mark R Somerfield
Pamela B Mangu
P304
P356
10.1200/JCO.2011.36.0354
P407
P577
2011-07-25T00:00:00Z